[Google Scholar] (138).Medoh UN
5) Practical Interpretation for Research If youre reading this from a biohacking or general wellness curiosity angle, the most useful takeaway is this: similarity in discussion does not equal similarity in mechanism
Switching to a different GLP-1 If cost is the primary driver, switching from tirzepatide to semaglutide may offer a more affordable alternative while maintaining GLP-1 receptor activation
When evaluating Cagrilintide vs Retatrutide, this targeted mechanism is what sets Cagrilintide apart
However, the risk for thyroid cancer was significantly higher within the first year after GLP-1RA initiation and was amplified in the overall as-treated analysis that censored patients when therapy was discontinued or another medication was added. The research team indicates this could be a sign that GLP-1 users are being screened for thyroid cancer at a higher rate than other diabetes drugs, resulting in a spike in diagnoses in the first year of taking the drug
Efficacy and Safety of Retatrutide, a GIP, GLP-1, and Glucagon Receptor Agonist Once Weekly for Weight Management: A Randomised, Double-Blind, Placebo-Controlled Trial
